Amgen Q4 Earnings: Strong Pipeline And Label Expansions Justify Buy Rating

Core Insights - Amgen Inc. reported strong earnings for Q4, surpassing analyst expectations for both earnings and revenue [1] - The company provided 2025 guidance that aligns with analyst expectations, indicating stability in future performance [1] Financial Performance - Amgen's Q4 earnings exceeded analyst forecasts, showcasing robust financial health [1] - Revenue figures were also above expectations, reflecting strong operational performance [1] Future Outlook - The 2025 guidance initiated by Amgen is generally in line with what analysts anticipated, suggesting confidence in continued growth [1]